Orladeyo 150MG caps
Ended Awarded Last action
- Contract number
- 36C26024F0258
- Awardee
-
Biocryst Pharmaceuticals Inc. UEI MGXADJ6SCLJ5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $201,722
Award facts
- Contract value 100% obligated
- $201,721.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded to Biocryst Pharmaceuticals Inc., a biotechnology company that specializes in developing small molecule drugs for rare diseases. The contract is valued at $201,721.59 and has an ultimate completion date of October 4, 2024. The contract is for the delivery of ORLADEYO 150MG CAPS, a pharmaceutical product used to treat hereditary angioedema. The contract was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 20, under the Federal Supply Schedule (FSS) for Pharmaceuticals and Drugs (FSS-61-IB). This contract is a delivery order under Biocryst's multiple-award FSS contract (36F79721D0166) with a $1.25 million ceiling and an ultimate completion date of May 14, 2026. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C26024F0258?
36C26024F0258 was awarded to Biocryst Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 4, 2024.
How much is contract 36C26024F0258 worth?
The government has obligated $201,722 on 36C26024F0258.
Is contract 36C26024F0258 an order under another contract?
Yes. 36C26024F0258 is a delivery order under 36F79721D0166, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0258 competed?
The extent of competition for 36C26024F0258 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award